A Phase 2, Randomized, Double-Blind, Single-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Naproxen [Test] Capsules for the Treatment of Pain After Surgical Removal of Impacted Third Molars.

Trial Profile

A Phase 2, Randomized, Double-Blind, Single-Dose, Parallel-Group, Active- and Placebo-Controlled Study of Naproxen [Test] Capsules for the Treatment of Pain After Surgical Removal of Impacted Third Molars.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Oct 2013

At a glance

  • Drugs Naproxen (Primary)
  • Indications Dental pain; Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Iroko Pharmaceuticals
  • Most Recent Events

    • 15 Oct 2013 Results published in Advances in Therapy.
    • 19 May 2012 Results presented at the 31st Annual Scientific Meeting of the American Pain Society.
    • 28 Mar 2012 Actual patient number changed from 253 to 254 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top